Authors:
Dougados, M
Nguyen, M
Berdah, L
Mazieres, B
Vignon, E
Lequesne, M
Acquaviva, P
Alcalay, M
Blotman, F
Combe, B
Dehais, J
Delcambre, B
Euller-Ziegler, L
Kuntz, JL
Larget-Piet, B
Le Loet, X
Llorca, G
Loyau, G
Maheu, E
Marcelli, C
Menkes, CJ
Paolaggi, JB
Pawlotsky, Y
Phelip, X
Pourel, J
Sebert, JL
Tavernier, C
Treves, R
Valat, JP
Citation: M. Dougados et al., Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis - ECHODIAH, a three-year, placebo-controlled trial, ARTH RHEUM, 44(11), 2001, pp. 2539-2547
Authors:
Mischis-Troussard, C
Goudet, P
Verges, B
Cougard, P
Tavernier, C
Maillefert, JF
Citation: C. Mischis-troussard et al., Primary hyperparathyroidism with normal serum intact parathyroid hormone levels, QJM-MON J A, 93(6), 2000, pp. 365-367
Authors:
Maillefert, JF
Tonolli-Serabian, I
Cherasse, A
Demoux, AL
Tavernier, C
Piroth, L
Citation: Jf. Maillefert et al., Arthritis following combined vaccine against diphtheria, polyomyelitis, and tetanus toxoid, CLIN EXP RH, 18(2), 2000, pp. 255-256
Authors:
Leray, JL
Paillet, P
Ferlet-Cavrois, V
Tavernier, C
Belhaddad, K
Penzin, O
Citation: Jl. Leray et al., Impact of technology scaling in SOI back-channel total dose tolerance. A 2-C numerical study using self-consistent oxide code, IEEE NUCL S, 47(3), 2000, pp. 620-626
Citation: Jf. Maillefert et al., Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin - A retrospective study, CANCER, 88(7), 2000, pp. 1759-1760
Authors:
Maillefert, JF
Tavernier, C
Sibilia, J
Vignon, E
Citation: Jf. Maillefert et al., Exacerbation of systemic lupus erythematosus after hepatitis B vaccination: comment on the article by Battafarano et al and the letter by Senecal et al, ARTH RHEUM, 43(2), 2000, pp. 468-468
Authors:
Maillefert, JF
Duchamp, O
Solary, E
Genne, P
Tavernier, C
Citation: Jf. Maillefert et al., Effects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells, ANN RHEUM D, 59(2), 2000, pp. 146-148
Authors:
Maillefert, JF
Sibilia, J
Toussirot, E
Vignon, E
Eschard, JP
Lorcerie, B
Juvin, R
Parchin-Geneste, N
Piroth, C
Wendling, D
Kuntz, JL
Tavernier, C
Gaudin, P
Citation: Jf. Maillefert et al., Rheumatic disorders developed after hepatitis B vaccination, RHEUMATOLOG, 38(10), 1999, pp. 978-983
Authors:
Milas, L
Maillefert, JF
Michel, F
Piroth, C
Wautot, A
Tavernier, C
Citation: L. Milas et al., Refractory arthropathy after intravesical bacillus Calmette-Guerin therapy- Usefulness of isoniazide, REV RHUM, 66(2), 1999, pp. 106-108
Authors:
Maillefert, JF
Sibilia, J
Michel, F
Saussine, C
Javier, RM
Tavernier, C
Citation: Jf. Maillefert et al., Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma, J UROL, 161(4), 1999, pp. 1219-1222
Authors:
Roche, P
Palau, JM
Bruguier, G
Tavernier, C
Ecoffet, R
Gasiot, J
Citation: P. Roche et al., Determination of key parameters for SEU occurrence using 3-D full cell SRAM simulations, IEEE NUCL S, 46(6), 1999, pp. 1354-1362
Citation: Jf. Maillefert et C. Tavernier, Pyrophosphate arthritis after intraarticular injection of hyaluronan: comment, ARTH RHEUM, 42(3), 1999, pp. 594-594